pretickt

Centene Corp. (CNC)

Healthcare · end-of-day data as of Oct 16, 2026

Centene Corp.
CNC · $34.16B
$69.16+9.1%last 60 sessions · close Oct 16, 2026
$31.80$70.5152 weeks
Hold · 21 analystsPT $68.80 -0.5%
  • P/E vs own—
  • P/E vs sector—
  • Target upside-0.5%
  • Off 52w high-1.9%
  • Insiders-$6.89M
  • FCF yield+26.2%
  • Earnings in11d
  • Trendsideways
  • Sector▲ +16.0%
  • RSI62
  • MA20×50—
  • Volume0.8x
  • Support-0.8%
  • Resistance—

The average 12-month analyst price target for CNC is $68.80, 0.5% below the last close of $69.16 on Oct 16, 2026; targets range from $39.16 to $80.96. Rating consensus: Hold.

Snapshot

  • P/E—
  • P/E vs sector—
  • P/E vs own—
  • Target upside-0.5%
  • ConsensusHold
  • Market cap$34.16B
  • FCF yield+26.2%
  • Insiders-$6.89M
  • Earnings in11d
  • News

Why it moved

Centene Corp. (CNC) fell 1.9% on Oct 16, 2026.

The market (SPY) fell 1.1%; Healthcare stocks fell 0.7%. Most of the move is specific to CNC.

Market (SPY)-1.1%
Healthcare sector+0.4%
CNC specific-1.2%

1 story on the day (30-day average 1.0).

Market = SPY. Sector = equal-weight average of the tracked companies in the same sector, net of the market.

Price and events

⇔⇕$34.32$45.54$56.77$67.99Oct 25Jan 26Apr 26Jul 26Oct 26EAEEAAEAE

Last close $69.16 · +94.1% over 1y · E earnings · D dividend · S split · A analyst rating change

Technicals

  • Trendsideways
  • Sector▲ +16.0%
  • MAs20▲ 50▲ 100▲ 200▲
  • Above MAs4 of 4 above
  • MA20×50—
  • RSI62
  • Support-0.8%
  • Resistance—
  • Off 52w high-1.9%
  • Off ATH-28.9%
  • 52w range$69.16
  • Bollingerupper half
  • MACD0.80
  • ATR+3.1%
  • Volume0.8x

Analyst price targets

Low$39.16
Average$68.80
Median$69.96
High$80.96
Upside-0.5%

17 firms with a target in the last 12 months · last close $69.16 · as of Oct 16, 2026

⇔⇕$29.34$42.86$56.38$69.90$83.41Oct 25Feb 26Jun 26Oct 26Feb 27Jun 27-45%-35%-15%-36%-40%-6%+14%+8%
— actual price● bullish target● bearish targethover a dot to see the analysts behind it · wheel or drag to move through time · drag the price axis on the right to stretch it · double-click resets

Strong buy 1 · Buy 7 · Hold 12 · Sell 1 · Strong sell 0

Revenue and free cash flow

Q2 FY2026: Revenue -9.0% year over year, free cash flow 9.5% of revenue, operating margin 3.1%.

RevenueFree cash flow
Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026
Q2 FY2026Jun 30, 2026$44.38B2.19$4.2B10.4%3.1%2.5%
Q1 FY2026Mar 31, 2026$49.94B3.11$3.4B21.9%3.7%3.1%
Q4 FY2025Dec 31, 2025$49.73B-2.24$224M15.2%-3.5%-2.2%
Q3 FY2025Sep 30, 2025$49.69B-13.50$1.15B16.4%-14.0%-13.3%
Q2 FY2025Jun 30, 2025$48.74B-0.51$1.58B6.0%-0.9%-0.5%
Q1 FY2025Mar 31, 2025$46.62B2.63$1.38B11.2%3.3%2.8%
Q4 FY2024Dec 31, 2024$40.8B0.56-$741M9.1%0.4%0.7%
Q3 FY2024Sep 30, 2024$42.02B1.36-$1.13B9.6%1.6%1.7%

Peers

20D
1UNHUnitedHealth Group Incorporated$401.43-1.3%-7.4%+14.6%22.9$360B
2CVSCVS Health Corp.$92.36-0.2%-16.0%+20.9%24.4$118B
3ELVElevance Health Inc.$428.260.0%0.0%+1.9%19.0$92.88B
4CICigna Corporation$302.30+1.2%-0.2%+10.9%12.5$79.88B
5HUMHumana Inc.$413.16-4.4%-4.7%+15.7%39.1$49.63B
6BIIBBiogen Inc.$232.65-1.1%-1.1%+2.7%41.2$34.37B
7CNCCentene Corp.$69.16-1.9%-1.9%-0.5%—$34.16B
8RMDResMed Inc.$238.97-1.3%-12.7%+3.7%23.0$33.61B

Data as of Oct 16, 2026 close.

Latest news